CTLA-4, or Cytotoxic T-Lymphocyte Antigen 4, is an immune checkpoint receptor that downregulates immune responses by inhibiting T-cell activation. It plays a crucial role in maintaining immune homeostasis and is a target for cancer immunotherapy, as blocking CTLA-4 can enhance anti-tumor immunity.